News

Rise of accountable care organizations (ACOs) could raise the importance of outpatient pharmacies to life sciences manufacturers

Healthcare supply-chain group offers free planning and educational resources

Billy Tauzin’s PhRMA legacy and the 'broccoli horrible' discussion

Battelle's biennial survey adds 'bioscience-related distribution' to industry sectors it tracks

Continuing growth attracts more players; meanwhile, Sensitech acquires FreightWatch International to beef up real-time monitoring

Continuing growth attracts more players; meanwhile, Sensitech acquires FreightWatch International to beef up real-time monitoring

Novartis could overtake Pfizer as No. 1, while Merck's Januvia/Janumet franchise will approach $10 billion in annual sales

Attempts were made to relabel stolen product with counterfeit labels, says NJ Star-Ledger

Combination will create the world's largest single buyer of pharmaceuticals

FedEx takes precautionary steps to manage CO2 outgassing in their newest B-777 aircraft

Meanwhile, all eyes were on the Supreme Court’s expected ruling on Obamacare

Systech builds on its packaging execution/serialization capabilities with an acquisition

Private-equity firm builds a competitor in pharma sales analytics

Private-equity firm builds a competitor in pharma sales analytics

In-depth statistical analysis using ZS Associates and IMS Health prescriber data demonstrates the value of rep-sourced communication

Monoclonal antibodies (MAbs) for oncology will be initial target

The leading chain pharmacy steps up its role as healthcare provider and partner to pharma

Oncology combines some of the most life-changing therapeutic events with the most complex commercialization pathways. Rising costs of treatments simply add to the tension

Compiling and maintaining lists of healthcare provider contacts is a bigger and more important task than ever

House bill mostly parallels Senate’s S.3187; but lacks federal pedigree rules

Biopharma remains a bright spot in US and international economic activity, even while the overall outlook remains cloudy

Latest annual Progressions report highlights the shift to healthy behaviors

Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models

Merger is not expected to affect specialty-distribution agreements negatively

Ten-year BLS projection sees a healthy industry ahead

Patient office visits, prescription usage continued to decline

Pharma industry serves best as underwriter of healthcare providers' efforts

Covis Pharmaceuticals' business model is to acquire distribution rights to low-volume drugs